Renalytix Investor Relations Material
Latest events
Q2 2025
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc is a diagnostics company specializing in the development of tests that assess kidney health. The company integrates machine learning and clinical data to create predictive diagnostics aimed at improving kidney disease treatment. It serves healthcare providers and institutions through strategic collaborations and commercialization efforts. Renalytix Plc is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RENX
Country
🇬🇧 United Kingdom